Literature DB >> 7511175

Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells?

P Biswas1, G Poli, J M Orenstein, A S Fauci.   

Abstract

Infection with several DNA or RNA viruses induces a state of increased sensitivity to cell lysis mediated by tumor necrosis factor (TNF), particularly in the presence of gamma interferon (IFN-gamma). Infection of human cells with the human immunodeficiency virus (HIV) may induce a similar phenomenon. However, TNF and IFN-gamma are known upregulators of HIV replication, raising the question of the potential role of these cytokines in the selective elimination of cells infected with this virus. The present study demonstrates that chronically infected U1 cells were killed with much greater efficiency by costimulation with TNF-alpha and IFN-gamma than their uninfected parental cell line U937. However, synergistic induction of viral expression also occurred in U1 cells as a consequence of treatment with the two cytokines. Cell death in U1 cells was not caused by the massive production of virions, in that costimulation with glucocorticoid hormones and TNF-alpha or IFN-gamma resulted in high levels of virion production without cytopathicity. To investigate the nature of the selective cytotoxic effect observed in U1 cells costimulated with TNF-alpha plus IFN-gamma, a panel of uninfected cell clones was generated by limiting dilution of U937 cells and tested for response to TNF-alpha and/or IFN-gamma. In contrast to the uncloned bulk parental U937 cell line, most uninfected cell clones showed a very high susceptibility to being killed by TNF-alpha and IFN-gamma. Similar findings were obtained when both infected U1 cells and several uninfected U937 cell clones were costimulated with an anti-Fas monoclonal antibody in the presence of IFN-gamma, although, unlike cells stimulated with TNF-alpha, cells treated with anti-Fas antibody did not express virus. Therefore, the increased susceptibility to cytokine-mediated lysis observed in cell lines infected with HIV is likely due to the selection of preexisting cell clones rather than viral infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511175      PMCID: PMC236737     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor.

Authors:  L R Gooding; L W Elmore; A E Tollefson; H A Brady; W S Wold
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

2.  Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

Authors:  D Zagury; J Bernard; R Leonard; R Cheynier; M Feldman; P S Sarin; R C Gallo
Journal:  Science       Date:  1986-02-21       Impact factor: 47.728

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Cytokines alter production of HIV-1 from primary mononuclear phagocytes.

Authors:  Y Koyanagi; W A O'Brien; J Q Zhao; D W Golde; J C Gasson; I S Chen
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

5.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate.

Authors:  T M Folks; J Justement; A Kinter; S Schnittman; J Orenstein; G Poli; A S Fauci
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

7.  Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF.

Authors:  M J Chen; B Holskin; J Strickler; J Gorniak; M A Clark; P J Johnson; M Mitcho; D Shalloway
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

Review 8.  Cytokine modulation of HIV expression.

Authors:  G Poli; A S Fauci
Journal:  Semin Immunol       Date:  1993-06       Impact factor: 11.130

9.  In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma.

Authors:  G H Wong; J F Krowka; D P Stites; D V Goeddel
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

10.  Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.

Authors:  G H Wong; D V Goeddel
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

View more
  15 in total

1.  Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway.

Authors:  T Iwasaki; T Hamano; K Saheki; T Kuroiwa; Y Kataoka; Y Takemoto; A Ogata; J Fujimoto; E Kakishita
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 2.  Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease.

Authors:  D Kaplan; S Sieg
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 3.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

4.  Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination.

Authors:  S J Kent; S L Hu; L Corey; W R Morton; P D Greenberg
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  1,25-Dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-kappaB-independent enhancement of viral replication.

Authors:  P Biswas; M Mengozzi; B Mantelli; F Delfanti; A Brambilla; E Vicenzi; G Poli
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Tumor necrosis factor-alpha levels in HIV-1 seropositive injecting drug users.

Authors:  Raymond L Ownby; Adarsh M Kumar; J Benny Fernandez; Irina Moleon-Borodowsky; Louis Gonzalez; Seth Eisdorfer; Drenna Waldrop-Valverde; Mahendra Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-04       Impact factor: 4.147

Review 7.  Role of apoptosis in HIV disease pathogenesis.

Authors:  N Oyaizu; S Pahwa
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

8.  Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.

Authors:  Massimo Alfano; Nicolai Sidenius; Barbara Panzeri; Francesco Blasi; Guido Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

9.  Macroautophagy Regulation during HIV-1 Infection of CD4+ T Cells and Macrophages.

Authors:  Sophie Borel; Lucile Espert; Martine Biard-Piechaczyk
Journal:  Front Immunol       Date:  2012-05-07       Impact factor: 7.561

10.  A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells.

Authors:  G Franzoso; P Biswas; G Poli; L M Carlson; K D Brown; M Tomita-Yamaguchi; A S Fauci; U K Siebenlist
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.